You are here

Article Text

Article menu
Download PDFPDF
Letter
Resolution of conjunctival Kaposi sarcoma after institution of highly active antiretroviral therapy alone
  1. H A Leder1,
  2. A Galor1,
  3. G B Peters1,
  4. S R Kedhar1,
  5. J P Dunn1,
  6. J E Thorne1,2
  1. 1
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
  2. 2
    Department of Epidemiology, Center for Clinical Trials, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
  1. H A Leder, Wilmer Eye Institute, 550 North Broadway, Suite 700, Baltimore, MD, USA; hleder{at}nc.rr.com

http://dx.doi.org/10.1136/bjo.2007.116186

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We present a case of conjunctival Kaposi sarcoma that resolved after treatment with highly active antiretroviral therapy alone.

    Case report

    A 53-year-old man from Ghana was diagnosed with human immunodeficiency virus in July 2005 and presented on March 2006 with a 2-week history of itching, redness and pain in the right eye. His examination showed a large, mobile, slightly tender lesion of the conjunctiva, not involving caruncle (fig 1). At that time his CD4+ T cell count was 38 cells/μl. He had simultaneous lesions on his feet consistent with Kaposi sarcoma. Biopsy of his foot …

    View Full Text

    Footnotes

    • Funding: Supported by grants EY-13707 (J E Thorne) from the National Eye Institute, Bethesda, MD, USA.

    • Competing interests: None.